Table 2.
Antibiotics and antimalarials prescribed according to symptoms (N = 20,850 patients)
| Treatment | Gastrointestinal symptoms (n = 4,591) | Respiratory tract symptoms (n = 3,563) | Urinary symptoms (n = 227) | Skin symptoms (n = 1,593) | Malaria (n = 624) | Total of population (n = 20,850) |
|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Antibiotics | 949 (20.7) | 2,210 (62.0) | 118 (52.0) | 890 (55.9) | – | 6,210 (29.8) |
| Penicillin | 495 (10.8) | 1,937 (54.4) | 50 (22.0) | 334 (21.0) | – | 4,122 (19.8) |
| Quinolone | 407 (8.9) | 108 (3.0) | 61 (26.9) | 38 (2.4) | – | 1,098 (5.3) |
| Co-trimoxazole | 61 (1.3) | 199 (5.6) | 3 (1.3) | 535 (33.6) | – | 1,072 (5.1) |
| Cycline | 2 (0.04) | 0 | 7 (3.1) | 1 (0.1) | – | 12 (0.06) |
| Cephalosporin | 1 (0.02) | 3 (0.1) | 1 (0.4) | 0 | – | 9 (0.04) |
| Macrolide | 1 (0.02) | 1 (0.03) | 0 | 1 (0.1) | – | 8 (0.04) |
| Metronidazole* | 535 (11.7) | 35 (1.0) | 28 (12.3) | 35 (2.2) | – | 866 (4.2) |
| Antimalarials | – | – | – | – | 549 (88.0) | 549 (2.6) |
| Artemisinin-based combination | – | – | – | – | 502 (80.4) | 502 (2.4) |
| Quinine | – | – | – | – | 69 (11.1) | 69 (0.3) |
* Metronidazole is both an antibacterial and an antiparasitic drug.